Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China's Pilot DRG Reimbursement Systems Indicate Substantial Changes To Hospital Prescription Habits

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China is experimenting with pilot reimbursement programs that rely on diagnosis related groups (DRG) in cities across the country, looking for ways to reduce medical expenses

You may also be interested in...



New China Essential Drug List On The Way, Cardiovascular And Cancer Drugs May Be In Play

A new essential drug list is taking shape, says China Health Minister Chen Zhu. Analysts predict drugs like Pfizer’s Norvasc (amlodipine) may be added.

Korea's New DRG System Sparks Threats Against Health Ministry

Police are investigating threats triggered by the ministry’s plan to launch a mandatory diagnosis-related group system in July despite opposition from doctors.

Korea's New DRG System Sparks Threats Against Health Ministry

Police are investigating threats triggered by the ministry’s plan to launch a mandatory diagnosis-related group system in July despite opposition from doctors.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC078605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel